EichorEICHOR
Location: Ferrol Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Ferrol

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Complejo Hospitalario Universitario de Ferrol · Spanish Oncology Genito-Urinary Group · NCT06724159
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Complexo Hospitalario Universitario de Ferrol Hospital Unive · Amgen · NCT07037433
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Hosp. Arquitecto Marcide · Janssen Research & Development, LLC · NCT07499232
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospit · Eli Lilly and Company · NCT06937086
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
Phase N/A · Hospital Arquitecto Marcide · Inmunotek S.L. · NCT06782217
Thoracic Tumours Register
Phase N/A · Complejo Hospitalario Universitario de Ferrol · Spanish Lung Cancer Group · NCT02941458
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospit · Eli Lilly and Company · NCT06937099
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Instituto Gallego de Cirugía Ocular · Eli Lilly and Company · NCT07392190
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD
Phase 3 · Hospital Arquitecto Marcide de Ferrol · Takeda · NCT06405087
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Th
Phase 3 · Hospital Arquitecto Marcide - Complejo Hospitalario Universi · AbbVie · NCT05995353
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years
Phase 3 · Complejo Hospitalario Universitario de Ferrol · Norgine · NCT07218523
Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry
Phase N/A · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT06163807
Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software
NA · Complejo Hospitalario Universitario de Ferrol · Persei Vivarium · NCT06920160
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee
Phase 3 · Hospital Naval Ferrol · Novo Nordisk A/S · NCT07509307
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · Hospital Arquitecto Marcide - Complejo Hospitalario Universi · AbbVie · NCT06332534
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small
Phase N/A · Complejo Hospitalario Universitario de Ferrol - Hospital Nav · Regeneron Pharmaceuticals · NCT05363319
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Wh
Phase 3 · Kailera Clinical Site · Kailera · NCT07284875
Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Phase N/A · Complejo Hospitalario Universitario de Ferrol · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT03894228
Sacituzumab govitEcan in THYroid Cancers
Phase 2 · Complexo Hospitalario Universitario de Ferrol · Grupo Espanol de Tumores Neuroendocrinos · NCT06235216
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Phase N/A · Complejo Hospitalario Universitario de Ferrol · Manuel Monreal · NCT02832245
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasiv
Phase 3 · Hosp. Arquitecto Marcide · Janssen Research & Development, LLC · NCT06919965
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia
Phase 3 · Research Site · AstraZeneca · NCT07662135
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Col
Phase 3 · Hosp. Arquitecto Marcide · Janssen Research & Development, LLC · NCT07196748
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
Phase N/A · Complejo Hospitalario Universitario Del Ferrol · Fundación GECP · NCT06634199
Intraligamentary vs Inferior Alveolar Nerve Block for Pulpitis: A Randomized Clinical Trial
NA · Clínica Dental 4 · Aula Dental Avanzada · NCT07130760
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospit · Eli Lilly and Company · NCT07157774
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Phase 2 · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospit · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli · NCT06226883
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Phase 3 · Complejo Hospitalario Universitario de Ferrol · Takeda · NCT06100289
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospit · Eli Lilly and Company · NCT07165028
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabete
Phase 3 · Kailera Clinical Site · Kailera · NCT07284901
Look up another city
Look up another condition